In contrast, some Pir-PLGA NP-loaded AdSCs that reached the marginal site might have been able to enter the tumor even during the single treatment, inducing tumor cell and vascular apoptosis in the central site of the tumor, which effectively reduced the tumor size. The gene discussed is PIR; the disease is neoplasm.